These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6692783)

  • 1. [Bezafibrate-induced rhabdomyolysis in a patient with impaired kidney function].
    Haubenstock A; Schmidt P; Zazgornik J; Balcke P; Kopsa H; Sertl K
    Dtsch Med Wochenschr; 1984 Jan; 109(4):157-8. PubMed ID: 6692783
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bezafibrate myopathy in two patients with chronic renal failure].
    Inoue M; Jimi T; Machida H; Niwa Y; Wakayama Y
    Rinsho Shinkeigaku; 1992 Jul; 32(7):725-8. PubMed ID: 1291164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of fibrate-induced rhabdomyolysis with plasma exchange in ESRD.
    Yang KC; Fang CC; Su TC; Lee YT
    Am J Kidney Dis; 2005 Mar; 45(3):e57-60. PubMed ID: 15754265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bezafibrate-induced myoglobinuric kidney failure in a 54-year-old patient with diabetes mellitus type IIa].
    Cissewski K; Kienast K; Windeck R; Benker G; Reinwein D
    Med Klin (Munich); 1988 Mar; 83(5):174-7. PubMed ID: 3374444
    [No Abstract]   [Full Text] [Related]  

  • 5. [A case of acute rhabdomyolysis and acute renal insufficiency caused by the simultaneous use of furosemide and bezafibrate].
    Venzano C; Cordi GC; Corsi L; Dapelo M; De Micheli A; Grimaldi GP
    Minerva Med; 1990 Dec; 81(12):909-11. PubMed ID: 2280884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhabdomyolysis due to bezafibrate in CAPD patients. A role for dihydropyridine drugs?
    Weissgarten J; Zaidenstein R; Fishman S; Dishi V; Michovitz-Koren M; Averbukh Z; Golik A
    Perit Dial Int; 1999; 19(2):180-2. PubMed ID: 10357195
    [No Abstract]   [Full Text] [Related]  

  • 7. [Rhabdomyolysis and acute renal failure secondary to statins].
    Borrego FJ; Liébana A; Borrego J; Pérez del Barrio P; Gil JM; García Cortés MJ; Sánchez Perales C; Serrano P; Pérez Bañasco V
    Nefrologia; 2001; 21(3):309-13. PubMed ID: 11471312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhabdomyolysis and acute renal failure following a switchover of therapy between two fibric acid derivatives.
    Kamaliah MD; Sanjay LD
    Singapore Med J; 2001 Aug; 42(8):368-72. PubMed ID: 11764054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Case of secondary carnitine deficiency (in a patient undergoing hemodialysis), developing rhabdomyolysis due to dehydration and the action of a hypolipemic agent].
    Kawashima N; Shindo R; Fusegawa H; Sato F
    Nihon Naika Gakkai Zasshi; 1993 Dec; 82(12):2066-7. PubMed ID: 8294807
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rhabdomyolysis due to bezafibrate: a new case].
    Gas JM; Prados MC; Perdiguero M; Rivera F
    Med Clin (Barc); 1992 Feb; 98(4):156-7. PubMed ID: 1552772
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bezafibrate-induced myolysis and myoglobinuria in patients with impaired renal function].
    Rumpf KW; Barth M; Blech M; Kaiser H; Koop I; Arnold R; Scheler F
    Klin Wochenschr; 1984 Apr; 62(8):346-8. PubMed ID: 6727274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bezafibrate induced rhabdomyolysis.
    Kanterewicz E; Sanmartí R; Riba J; Trias I; Autonell J; Brugués J
    Ann Rheum Dis; 1992 Apr; 51(4):536-8. PubMed ID: 1586257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhabdomyolysis and acute renal failure associated with bezafibrate treatment.
    Górriz JL; Sancho A; Alcoy E; García-Ramos JL; Pallardó LM
    Nephrol Dial Transplant; 1995 Dec; 10(12):2371-2. PubMed ID: 8808248
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe rhabdomyolysis induced by a retard formulation of bezafibrate in a CAPD patient.
    Panuccio V; Enia G; Parlongo S; Cutrupi S; Zoccali C
    Nephron; 1996; 73(4):736. PubMed ID: 8856294
    [No Abstract]   [Full Text] [Related]  

  • 15. Bezafibrate-induced rhabdomyolysis.
    Malnick SD; Badir A; Landau Z
    DICP; 1991; 25(7-8):869-70. PubMed ID: 1949949
    [No Abstract]   [Full Text] [Related]  

  • 16. [A case report of acute neuromyopathy induced by concomitant use of colchicine and bezafibrate].
    Sugie M; Kuriki A; Arai D; Ichikawa H; Kawamura M
    No To Shinkei; 2005 Sep; 57(9):785-90. PubMed ID: 16248366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mizoribine-induced rhabdomyolysis in a rheumatoid arthritis patient receiving bezafibrate treatment.
    Morimoto S; Fujioka Y; Tsutsumi C; Masai M; Okumura T; Yuba M; Sakoda T; Tsujino T; Ohyanagi M
    Am J Med Sci; 2005 Apr; 329(4):211-3. PubMed ID: 15832106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predominance of lactate dehydrogenase isoenzyme 1 in a patient with bezafibrate-induced rhabdomyolysis.
    Haubenstock A; Schröcksnadel W; Bauer K; Schmidt P; Gabl F
    Clin Chem; 1984 Sep; 30(9):1587-8. PubMed ID: 6467582
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute rhabdomyolysis after bezafibrate re-exposure.
    Terrovitou CT; Milionis HJ; Elisaf MS
    Nephron; 1998; 78(3):336-7. PubMed ID: 9546698
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the synergistic adverse effects of concomitant therapy with statins and fibrates on rhabdomyolysis.
    Matzno S; Tazuya-Murayama K; Tanaka H; Yasuda S; Mishima M; Uchida T; Nakabayashi T; Matsuyama K
    J Pharm Pharmacol; 2003 Jun; 55(6):795-802. PubMed ID: 12841940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.